Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Prophase Labs (PRPH)
NASDAQ:PRPH
Holding PRPH?
Track your performance easily
Earnings Data
Report Date
Mar 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.24Last Year’s EPS
-0.51Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 15, 2018
|% Change Since: -18.92%
|Next Earnings Date:Aug 20, 2018
Earnings Call Sentiment|Neutral
The call highlighted several growth initiatives and product launches, particularly in the DNA and pharmaceutical sectors, indicating optimism for future growth. However, challenges with delayed government receivables and cash flow imbalances highlight ongoing financial concerns.Company Guidance
In the Q3 2024 earnings call for ProPhase Labs, CEO Ted Karkus provided comprehensive guidance, focusing on several key metrics and strategic initiatives. The company is aggressively launching DNA Complete and DNA Expand products to capitalize on the holiday season, underscoring their potential in the DNA and genomics market. Karkus highlighted the strong growth of Pharmaloz Manufacturing (PMI), projecting approximately $15 million in revenue and $5 million in pre-tax profit over the next 12 months, largely due to increased demand and pricing for lozenges. Additionally, he discussed potential liquidity events, including the sale of PMI, which could fetch valuations between $40 million to $50 million, and the development of the BE-Smart Esophageal Cancer Test, targeting a $7 billion to $14 billion market. The company is also working on reducing overhead expenses by at least $6 million, with an anticipated $11 million cash swing to the positive, supported by $5-plus million earnings from Pharmaloz next year. Karkus emphasized the strategic importance of partnering with major diagnostic companies for the cancer test and expressed optimism about securing government accounts receivable, which includes $70 million related to COVID testing.Aggressive Expansion and Product Launches
Capital was raised to support an aggressive launch for DNA Complete and DNA Expand, aiming to leverage the holiday season for higher sales.
PMI Manufacturing Growth
PMI is ramping up aggressively with more packaging, ingredients, and labor, indicating strong growth potential.
Cost Reduction Initiatives
A plan to reduce overhead and other expenses by at least $6 million is underway, potentially impacting more than $5 million in payables.
Esophageal Cancer Test Potential
The BE-Smart Esophageal Cancer Test is targeting a $7 billion to $14 billion market with plans to commercialize within a year.
Positive Financial Expectations
Anticipated earnings of at least $5 million next year for Pharmaloz, contributing to an $11 million positive cash swing.
---
PRPH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PRPH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 13, 2024 | $0.74 | $0.77 | +4.05% |
| Aug 14, 2024 | $2.47 | $2.50 | +1.21% |
| May 09, 2024 | $5.39 | $4.92 | -8.72% |
| Mar 15, 2024 | $4.86 | $5.04 | +3.70% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Prophase Labs (PRPH) report earnings?
Prophase Labs (PRPH) is schdueled to report earning on Mar 26, 2025, TBA Not Confirmed.
What is Prophase Labs (PRPH) earnings time?
Prophase Labs (PRPH) earnings time is at Mar 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PRPH EPS forecast?
PRPH EPS forecast for the fiscal quarter 2024 (Q4) is -0.24.
---